These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20361487)
21. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164 [TBL] [Abstract][Full Text] [Related]
22. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay. Yeim S; Bordachar P; Reuter S; Laborderie J; O'Neill MD; Lafitte S; Deplagne A; Garrigue S; Roudaut R; Jais P; Haissaguerre M; Dossantos P; Clementy J Pacing Clin Electrophysiol; 2007 Aug; 30(8):970-5. PubMed ID: 17669079 [TBL] [Abstract][Full Text] [Related]
23. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study. Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381 [TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronisation therapy: what a hospital practitioner needs to know? Albouaini K; Alkarmi A; Wright DJ Postgrad Med J; 2010 Jan; 86(1011):12-7; quiz 16. PubMed ID: 20065336 [TBL] [Abstract][Full Text] [Related]
26. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation. Ghanbari H; Hassunizadeh B; Machado C Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687 [TBL] [Abstract][Full Text] [Related]
27. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867 [TBL] [Abstract][Full Text] [Related]
28. Mechanical dyssynchrony from the perspective of a cardiac electrophysiologist. Beshai JF; Khunnawat C; Lin AC Curr Opin Cardiol; 2008 Sep; 23(5):447-51. PubMed ID: 18670255 [TBL] [Abstract][Full Text] [Related]
29. Cardiac resynchronization therapy in patients with a narrow QRS complex. Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254 [TBL] [Abstract][Full Text] [Related]
30. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction. Aronow WS Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919 [TBL] [Abstract][Full Text] [Related]
31. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
32. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients. Wein S; Voskoboinik A; Wein L; Billah B; Krum H J Card Fail; 2010 May; 16(5):432-8. PubMed ID: 20447580 [TBL] [Abstract][Full Text] [Related]
33. Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient. Abraham WT Rev Cardiovasc Med; 2003; 4 Suppl 2():S30-7. PubMed ID: 12776011 [TBL] [Abstract][Full Text] [Related]
34. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354 [TBL] [Abstract][Full Text] [Related]
35. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828 [TBL] [Abstract][Full Text] [Related]
36. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019 [TBL] [Abstract][Full Text] [Related]
37. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy? Gupta SN; Jose VJ; Chandy ST Indian Heart J; 2003; 55(6):619-23. PubMed ID: 14989512 [TBL] [Abstract][Full Text] [Related]
38. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]